Your search returned 9 results.

Results
	1.	[Cytokines and their antagonists in the treatment of rheumatoid arthritis]. [electronic resource] by Klimiuk, Piotr A Sierakowski, Stanisław Producer: 20020912 In: Przeglad lekarski vol. 59 Availability: No items available. Save to lists Add to cart (remove)
	2.	[Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis]. [electronic resource] by Klimiuk, Piotr A Sierakowski, Stanisław Chwiećko, Justyna Producer: 20031007 In: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego vol. 14 Availability: No items available. Save to lists Add to cart (remove)
	3.	[Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis]. [electronic resource] by Kuryliszyn-Moskal, Anna Klimiuk, Piotr A Sierakowski, Stanisław Producer: 20050421 In: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego vol. 17 Availability: No items available. Save to lists Add to cart (remove)
	4.	Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE [electronic resource] by Cohen, Stanley Klimiuk, Piotr A Krahnke, Tillmann Assudani, Deepak Producer: 20190204 In: Expert opinion on drug delivery vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	[The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon]. [electronic resource] by Kuryliszyn-Moskal, Anna Kita, Jacek Dakowicz, Agnieszka Klimiuk, Piotr A Producer: 20130307 In: Annales Academiae Medicae Stetinensis vol. 57 Availability: No items available. Save to lists Add to cart (remove)
	6.	Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. [electronic resource] by Klimiuk, Piotr A Sierakowski, Stanisław Domysławska, Izabela Fiedorczyk, Małgorzata Chwiećko, Justyna Producer: 20041110 In: Archivum immunologiae et therapiae experimentalis vol. 52 Availability: No items available. Save to lists Add to cart (remove)
	7.	Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. [electronic resource] by Vallejo, Abbe N Yang, Hongyu Klimiuk, Piotr A Weyand, Cornelia M Goronzy, Jörg J Producer: 20031031 In: Journal of immunology (Baltimore, Md. : 1950) vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext). [electronic resource] by Cohen, Stanley B Czeloth, Niklas Lee, Eric Klimiuk, Piotr A Peter, Nuala Jayadeva, Girish Producer: 20200420 In: Expert opinion on biological therapy vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study. [electronic resource] by Cohen, Stanley B Alonso-Ruiz, Alberto Klimiuk, Piotr A Lee, Eric C Peter, Nuala Sonderegger, Ivo Assudani, Deepak Producer: 20190805 In: Annals of the rheumatic diseases vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)